Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update
13/11/2024 13:09
Nov 13 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* VIRACTA THERAPEUTICS: CASH POSITION SUFFICIENT TO FUND
OPERATIONS LATE INTO Q1 2025
Source text: urn:newsml:reuters.com:*:nGNX3q35Vt
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update